SUN PHARMA ADVANCED RESEARCH COMPANY
Back to Balance Sheet
|
SUN PHARMA ADVANCED RESEARCH COMPANY Last 5 Year Total Current Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | |
|---|---|---|---|
| Total Current Liabilities | ₹374 Cr | ₹265 Cr | ₹179 Cr |
What is the latest Total Current Liabilities ratio of SUN PHARMA ADVANCED RESEARCH COMPANY ?
| Year | Total Current Liabilities |
|---|---|
| Mar2025 | ₹374 Cr |
| Mar2024 | ₹265 Cr |
| Mar2023 | ₹179 Cr |
How is Total Current Liabilities of SUN PHARMA ADVANCED RESEARCH COMPANY Trending?
| Years | Total Current Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹374 Cr | 41.19 | |
| Mar2024 | ₹265 Cr | 48.12 | |
| Mar2023 | ₹179 Cr | - | |
Compare Total Current Liabilities of peers of SUN PHARMA ADVANCED RESEARCH COMPANY
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SUN PHARMA ADVANCED RESEARCH COMPANY | ₹4,512.2 Cr | 4.3% | 1% | -11.9% | Stock Analytics | |
| SAGILITY INDIA | ₹22,568.7 Cr | -1.2% | -7.4% | -2.1% | Stock Analytics | |
| SYNGENE INTERNATIONAL | ₹18,049.7 Cr | -4.3% | -31.8% | -37.7% | Stock Analytics | |
| LATENT VIEW ANALYTICS | ₹8,820.2 Cr | -6.6% | -8% | -2.2% | Stock Analytics | |
| JUST DIAL | ₹5,695.0 Cr | 3.2% | -9.9% | -21.4% | Stock Analytics | |
| AWFIS SPACE SOLUTIONS | ₹2,594.0 Cr | -6.6% | -24.6% | -43.9% | Stock Analytics | |
SUN PHARMA ADVANCED RESEARCH COMPANY Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SUN PHARMA ADVANCED RESEARCH COMPANY | 4.3% |
1% |
-11.9% |
| SENSEX | 3.5% |
-1.7% |
7.8% |
You may also like the below Video Courses